H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 15.8% of adults in Hartford have diagnosed diabetes — 3.8 points above the U.S. 12% figure. Census population 121,054. Connecticut Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Hartford clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Hartford storefront.
Regenerative Medicine for Athletic Performance in Hartford, CT for clinics & physicians. Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 15.8% of adults in Hartford have diagnosed diabetes — 3.8 points above the U.S. 12% figure. Census city-proper population is 121,054. If you are adding regenerative medicine for athletes, start with that epidemiology and with National Government Services (NGS) (JK) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Regenerative Medicine for Athletic Performance notes (how the product actually works)CDC PLACES (2023, crude) estimates 15.8% of adults in Hartford have diagnosed diabetes — 3.8 points above the U.S. 12% figure. Adult obesity in Hartford is 40.4% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 23.1% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JK / National Government Services (NGS), sibling states MA, ME, NH, NY, RI, VT. Connecticut Department of Public Health is the public-health home. We will not mash those grains into a fake “demand score.”
We are not going to invent a Hartford warehouse or a five-star local review. What you get is regenerative medicine for athletes from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JK, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 15.8% of adults — 3.8 points above the U.S. 12% figure. Obesity is 40.4%; arthritis is 23.1%. That is place-level BRFSS modeling, not a clinic census and not a Hartford trial.
Start with the CDC National Diabetes Statistics Report and America's Health Rankings diabetes measure (BRFSS). Connecticut Department of Public Health is the state public-health home. Those are the citable sources — not this page’s city name in a headline.
Regulatory lane, storage, and JK coding. Amniotic products used as 361 HCT/Ps are not “better gauze.” Match wound stage and coverage article before you convert the cart.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Connecticut.
Ask for the IFU, the lot-traceability packet, and the National Government Services (NGS) article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Hartford fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Hartford, CT.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Hartford is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Hartford — 3.8 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Connecticut Part B wound biologics follow this contractor (siblings: MA, ME, NH, NY, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Hartford. Useful for joint-program math; still needs a diagnosis and privileging.
No Hartford storefront. Joe Bradley is an active practice owner. regenerative medicine for athletes stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.